Business
DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTION
DOMA Perpetual Capital Management ("DOMA Perpetual") is a fundamentals-based, value-oriented asset management firm, which, together with its affiliates (collectively, "DOMA" or "we"), beneficially owns approximately 7.5% of the outstanding shares of common stock of Pacira BioSciences, Inc. (NASDAQ: PCRX) ("Pacira" or the "Company").
About this update from Pacira Biosciences, Inc.
[{"type":"text","content":"PACIRA'S STOCK PRICE IS DOWN FOR EVERY RECENT PERIOD: 10 YEAR, 5 YEAR, 3 YEAR, 2 YEAR, ONE YEAR, AND YEAR-TO-DATE","length":117,"tagName":"p","attribs":{}},{"type":"text","content":"DOMA BELIEVES MANAGEMENT IS MISLEADING STAKEHOLDERS REGARDING ITS PATENT PROTECTION AND MINIMIZING THE POTENTIAL BUSINESS-DESTROYING CONSEQUENCES OF ANOTHER LEGAL LOSS, CONSTITUTING GROSS NEGLIGENCE","length":198,"tagName":"p","attribs":{}},{"type":"text","content":"DOMA CONTENDS THE BOARD IS REFUSING TO EXPLORE A SALE BECAUSE DIRECTORS DO NOT WANT TO LOSE THEIR JOBS, PUTTING THEIR INTERESTS AHEAD OF SHAREHOLDERS","length":149,"tagName":"p","attribs":{}},{"type":"text","content":"MIAMI, May 28, 2026 /PRNewswire/ -- DOMA Perpetual Capital Management ("DOMA Perpetual") is a fundamentals-based, value-oriented asset management firm, which, together with its affiliates (collectively, "DOMA" or "we"), beneficially owns approximately 7.5% of the outstanding shares of common stock of Pacira BioSciences, Inc. (NASDAQ: PCRX) ("Pacira" or the "Company").","length":420,"tagName":"p"},{"type":"image","alt":"DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual)","displaySize":"","headline":null,"caption":"DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":118,"url":"https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/NgKCrMfj16DkteLv.vpYsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIwOA--/https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3","width":400,"height":118},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/M5.Yxu79WNVQQZU3S_9XEQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE4OQ--/https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3","width":400,"height":118}},"href":"https://mma.prnewswire.com/media/2468496/DOMA_Perpetual_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"While the Company has repeatedly highlighted the strength of its patent portfolio and related protections, the market's response is a clear indication that investors remain unconvinced. This disconnect is further reflected in the Company's share price, which has declined across virtual...